Abstract
Serum paraoxonase 1 (PON1) is highly fucosylated in hepatocellular carcinoma (HCC) compared with liver cirrhosis (LC). Herein, lectin ELISA using Aleuria aurantia lectin (AAL) was established, which specifically measured optical density (OD) value of serum fucosylated PON1. PON1 protein ELISA was applied simultaneously. ELISA Index (OD value of fucosylated PON1/OD value of protein PON1) was introduced to indicate PON1 fucosylation level on its protein level (Fuc-PON1). ELISA Index in training group (90 LC and 90 HCC) was measured and area under the ROC curve (AUROC) was 0.803 with 80 % of sensitivity and 64.4 % of specificity in distinguishing early HCC from LC. Within training group, AFP− HCC (20/90) exhibited better AUROC (0.850), higher sensitivity (90 %) and specificity (75 %) than AFP+ HCC (70/90). An independent testing set (20 LC and 20 HCC) validated the model and 17 HCC patients were successfully predicted. Meanwhile, serum AFP of 43 LC and 43 HCC had an AUROC of 0.760 with sensitivity of 79.1 % and specificity of 53.5 %. Thus, Fuc-PON1 may serve as a glycan biomarker for distinguishing early HCC from LC patients even with low AFP levels.
Similar content being viewed by others
References
Parkin, D.M., Bray, F., Ferlay, J., Pisani, P.: Global cancer statistics, 2002. CA Cancer J. Clin. 55(2), 74–108 (2005)
Caturelli, E., Bartolucci, F., Biasini, E., Vigliotti, M.L., Andriulli, A., Siena, D.A., Attino, V., Bisceglia, M.: Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma. Am. J. Gastroenterol. 97(2), 397–405 (2002). doi:10.1111/j.1572-0241.2002.05477.x
Colli, A., Fraquelli, M., Casazza, G., Massironi, S., Colucci, A., Conte, D., Duca, P.: Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am. J. Gastroenterol. 101(3), 513–523 (2006). doi:10.1111/j.1572-0241.2006.00467.x
Oka, H., Saito, A., Ito, K., Kumada, T., Satomura, S., Kasugai, H., Osaki, Y., Seki, T., Kudo, M., Tanaka, M.: Collaborative Hepato-Oncology Study Group of J: multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein. J. Gastroenterol. Hepatol. 16(12), 1378–1383 (2001)
Sato, Y., Nakata, K., Kato, Y., Shima, M., Ishii, N., Koji, T., Taketa, K., Endo, Y., Nagataki, S.: Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N. Engl. J. Med. 328(25), 1802–1806 (1993). doi:10.1056/NEJM199306243282502
Ohtsubo, K., Marth, J.D.: Glycosylation in cellular mechanisms of health and disease. Cell 126(5), 855–867 (2006). doi:10.1016/j.cell.2006.08.019
Dwek, R.A.: Glycobiology: toward understanding the function of sugars. Chem. Rev. 96(2), 683–720 (1996)
Precourt, L.P., Amre, D., Denis, M.C., Lavoie, J.C., Delvin, E., Seidman, E., Levy, E.: The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis 214(1), 20–36 (2011). doi:10.1016/j.atherosclerosis.2010.08.076
Bunkenborg, J., Pilch, B.J., Podtelejnikov, A.V., Wisniewski, J.R.: Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. Proteomics 4(2), 454–465 (2004). doi:10.1002/pmic.200300556
Chen, R., Jiang, X., Sun, D., Han, G., Wang, F., Ye, M., Wang, L., Zou, H.: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J. Proteome Res. 8(2), 651–661 (2009). doi:10.1021/pr8008012
Liu, T., Qian, W.J., Gritsenko, M.A., Camp 2nd, D.G., Monroe, M.E., Moore, R.J., Smith, R.D.: Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J. Proteome Res. 4(6), 2070–2080 (2005). doi:10.1021/pr0502065
Ferre, N., Marsillach, J., Camps, J., Mackness, B., Mackness, M., Riu, F., Blai, C., Tous, M., Joven, J.: Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases. J. Hepatol. 45(1), 51–59 (2006). doi:10.1016/j.jhep.2005.12.018
Huang, C., Wang, Y.W., Liu, S.D., Ding, G.Y., Liu, W.R., Zhou, J., Kuang, M., Ji, Y., Kondo, T., Fan, J.: Quantitative proteomic analysis identified paraoxonase 1 as a novel serum biomarker for microvascular invasion in hepatocellular carcinoma. J. Proteome Res. 12(4), 1838–1846 (2013). doi:10.1021/Pr3011815
Sun, C., Chen, P., Chen, Q., Sun, L., Kang, X., Qin, X., Liu, Y.: Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients. Acta. Biochim. Biophys. Sin. (Shanghai) 44(9), 765–773 (2012). doi:10.1093/abbs/gms055
Nakano, M., Nakagawa, T., Ito, T., Kitada, T., Hijioka, T., Kasahara, A., Tajiri, M., Wada, Y., Taniguchi, N., Miyoshi, E.: Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers. Int. J. Cancer 122(10), 2301–2309 (2008). doi:10.1002/ijc.23364
Miyoshi, E., Moriwaki, K., Nakagawa, T.: Biological function of fucosylation in cancer biology. J. Biochem. 143(6), 725–729 (2008). doi:10.1093/jb/mvn011
Zhang, S., Shu, H., Luo, K.X., Kang, X.N., Zhang, Y., Lu, H.J., Liu, Y.K.: N-linked glycan changes of serum haptoglobin beta chain in liver disease patients. Mol. BioSyst. 7(5), 1621–1628 (2011). doi:10.1039/C1mb05020f
Zhang, S., Jiang, K., Sun, C., Lu, H.J., Liu, Y.K.: Quantitative analysis of site-specific N-glycans on sera haptoglobin beta chain in liver diseases. Acta Biochim. Biophys. Sin 45(12), 1021–1029 (2013). doi:10.1093/Abbs/Gmt110
Okuyama, N., Ide, Y., Nakano, M., Nakagawa, T., Yamanaka, K., Moriwaki, K., Murata, K., Ohigashi, H., Yokoyama, S., Eguchi, H., Ishikawa, O., Ito, T., Kato, M., Kasahara, A., Kawano, S., Gu, J.G., Miyoshi, E.: Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for Fucosylation. Int. J. Cancer 118(11), 2803–2808 (2006). doi:10.1002/Ijc.21728
Matsumura, K., Higashida, K., Ishida, H., Hata, Y., Yamamoto, K., Shigeta, M., Mizuno-Horikawa, Y., Wang, X.C., Miyoshi, E., Gu, J.G., Taniguchi, N.: Carbohydrate binding specificity of a fucose-specific lectin from aspergillus oryzae - A novel probe for core fucose. J. Biol. Chem. 282(21), 15700–15708 (2007). doi:10.1074/jbc.M701195200
Ahn, J.M., Sung, H.J., Yoon, Y.H., Kim, B.G., Yang, W.S., Lee, C., Park, H.M., Kim, B.J., Kim, B.G., Lee, S.Y., An, H.J., Cho, J.Y.: Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer. Mol. Cell. Proteomics 13(1), 30–48 (2014). doi:10.1074/mcp.M113.028621
Matsumoto, H., Shinzaki, S., Narisada, M., Kawamoto, S., Kuwamoto, K., Moriwaki, K., Kanke, F., Satomura, S., Kumada, T., Miyoshi, E.: Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer. Clin. Chem. Lab. Med. 48(4), 505–512 (2010). doi:10.1515/CCLM.2010.095
Wu, J., Xie, X., Liu, Y., He, J., Benitez, R., Buckanovich, R.J., Lubman, D.M.: Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS. J. Proteome Res. 11(9), 4541–4552 (2012). doi:10.1021/pr300330z
Acknowledgments
The work was financially supported by National Science and Technology Key Projects of China (2011CB910604), China National Key Projects for Infectious Disease (2012ZX10002-009 and 2012ZX10002-012).
Conflict of interest
The authors have declared no conflict of interest.
Compliance with Ethical Standards
The serum specimens were obtained from the First Affiliated Hospital of Guangxi Medical University. This study was approved by the Research Ethics committee of First Affiliated Hospital of Guangxi Medical University and the Institutional Review Board of the National Cancer Center. Informed consent was obtained from each patient.
Author information
Authors and Affiliations
Corresponding author
Additional information
Shu Zhang and Kai Jiang contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhang, S., Jiang, K., Zhang, Q. et al. Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index. Glycoconj J 32, 119–125 (2015). https://doi.org/10.1007/s10719-015-9576-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-015-9576-8